vs
Brixmor Property Group Inc.（BRX）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
Brixmor Property Group Inc.的季度营收约是REPLIGEN CORP的1.8倍（$354.8M vs $197.9M），Brixmor Property Group Inc.净利率更高（36.0% vs 6.7%，领先29.3%），REPLIGEN CORP同比增速更快（13.6% vs 5.1%），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs 6.0%）
Brixmor Property Group是一家公开上市的房地产投资信托（REIT），核心业务为投资购物中心类商业地产，专注于挖掘零售不动产的商业价值，在为股东创造稳定投资回报的同时，也为入驻商户的运营发展提供物业配套支持。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
BRX vs RGEN — 直观对比
营收规模更大
BRX
是对方的1.8倍
$197.9M
营收增速更快
RGEN
高出8.5%
5.1%
净利率更高
BRX
高出29.3%
6.7%
两年增速更快
RGEN
近两年复合增速
6.0%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $354.8M | $197.9M |
| 净利润 | $127.8M | $13.3M |
| 毛利率 | — | 52.5% |
| 营业利润率 | 37.8% | 9.0% |
| 净利率 | 36.0% | 6.7% |
| 营收同比 | 5.1% | 13.6% |
| 净利润同比 | 83.2% | 143.9% |
| 每股收益（稀释后） | $0.41 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BRXRGEN
| Q1 26 | $354.8M | — | ||
| Q4 25 | $353.8M | $197.9M | ||
| Q3 25 | $340.8M | $188.8M | ||
| Q2 25 | $339.5M | $182.4M | ||
| Q1 25 | $337.5M | $169.2M | ||
| Q4 24 | $328.4M | $174.1M | ||
| Q3 24 | $320.7M | $154.9M | ||
| Q2 24 | $315.7M | $154.1M |
净利润BRXRGEN
| Q1 26 | $127.8M | — | ||
| Q4 25 | $137.1M | $13.3M | ||
| Q3 25 | $94.2M | $14.9M | ||
| Q2 25 | $85.1M | $14.9M | ||
| Q1 25 | $69.7M | $5.8M | ||
| Q4 24 | $83.4M | $-30.3M | ||
| Q3 24 | $96.8M | $-654.0K | ||
| Q2 24 | $70.1M | $3.3M |
毛利率BRXRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 50.0% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 50.0% | ||
| Q2 24 | — | 49.8% |
营业利润率BRXRGEN
| Q1 26 | 37.8% | — | ||
| Q4 25 | — | 9.0% | ||
| Q3 25 | — | 8.9% | ||
| Q2 25 | — | 7.6% | ||
| Q1 25 | — | 3.9% | ||
| Q4 24 | — | -17.7% | ||
| Q3 24 | — | -5.1% | ||
| Q2 24 | — | 1.0% |
净利率BRXRGEN
| Q1 26 | 36.0% | — | ||
| Q4 25 | 38.8% | 6.7% | ||
| Q3 25 | 27.6% | 7.9% | ||
| Q2 25 | 25.1% | 8.2% | ||
| Q1 25 | 20.7% | 3.4% | ||
| Q4 24 | 25.4% | -17.4% | ||
| Q3 24 | 30.2% | -0.4% | ||
| Q2 24 | 22.2% | 2.2% |
每股收益（稀释后）BRXRGEN
| Q1 26 | $0.41 | — | ||
| Q4 25 | $0.43 | $0.24 | ||
| Q3 25 | $0.31 | $0.26 | ||
| Q2 25 | $0.28 | $0.26 | ||
| Q1 25 | $0.23 | $0.10 | ||
| Q4 24 | $0.27 | $-0.55 | ||
| Q3 24 | $0.32 | $-0.01 | ||
| Q2 24 | $0.23 | $0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $323.9M | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $3.0B | $2.1B |
| 总资产 | $9.1B | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资BRXRGEN
| Q1 26 | $323.9M | — | ||
| Q4 25 | $334.4M | $767.6M | ||
| Q3 25 | $331.5M | $748.7M | ||
| Q2 25 | $105.0M | $708.9M | ||
| Q1 25 | $106.5M | $697.2M | ||
| Q4 24 | $377.6M | $757.4M | ||
| Q3 24 | $451.3M | $784.0M | ||
| Q2 24 | $473.6M | $809.1M |
总债务BRXRGEN
| Q1 26 | — | — | ||
| Q4 25 | $5.5B | $542.2M | ||
| Q3 25 | $5.5B | $537.9M | ||
| Q2 25 | $5.1B | — | ||
| Q1 25 | $5.1B | — | ||
| Q4 24 | $5.3B | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益BRXRGEN
| Q1 26 | $3.0B | — | ||
| Q4 25 | $3.0B | $2.1B | ||
| Q3 25 | $3.0B | $2.1B | ||
| Q2 25 | $3.0B | $2.1B | ||
| Q1 25 | $3.0B | $2.0B | ||
| Q4 24 | $3.0B | $2.0B | ||
| Q3 24 | $2.9B | $2.0B | ||
| Q2 24 | $2.9B | $2.0B |
总资产BRXRGEN
| Q1 26 | $9.1B | — | ||
| Q4 25 | $9.1B | $2.9B | ||
| Q3 25 | $9.0B | $2.9B | ||
| Q2 25 | $8.6B | $2.9B | ||
| Q1 25 | $8.6B | $2.9B | ||
| Q4 24 | $8.9B | $2.8B | ||
| Q3 24 | $8.7B | $2.8B | ||
| Q2 24 | $8.7B | $2.9B |
负债/权益比BRXRGEN
| Q1 26 | — | — | ||
| Q4 25 | 1.83× | 0.26× | ||
| Q3 25 | 1.85× | 0.26× | ||
| Q2 25 | 1.73× | — | ||
| Q1 25 | 1.73× | — | ||
| Q4 24 | 1.79× | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $25.7M |
| 自由现金流经营现金流 - 资本支出 | — | $17.6M |
| 自由现金流率自由现金流/营收 | — | 8.9% |
| 资本支出强度资本支出/营收 | 3.4% | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | — | $93.9M |
8季度趋势，按日历期对齐
经营现金流BRXRGEN
| Q1 26 | — | — | ||
| Q4 25 | $652.0M | $25.7M | ||
| Q3 25 | $168.3M | $48.1M | ||
| Q2 25 | $181.5M | $28.6M | ||
| Q1 25 | $130.1M | $15.0M | ||
| Q4 24 | $624.7M | $39.2M | ||
| Q3 24 | $157.5M | $49.3M | ||
| Q2 24 | $183.5M | $42.2M |
自由现金流BRXRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | $17.6M | ||
| Q3 25 | — | $43.4M | ||
| Q2 25 | — | $21.5M | ||
| Q1 25 | — | $11.4M | ||
| Q4 24 | — | $33.6M | ||
| Q3 24 | — | $42.3M | ||
| Q2 24 | — | $37.4M |
自由现金流率BRXRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 8.9% | ||
| Q3 25 | — | 23.0% | ||
| Q2 25 | — | 11.8% | ||
| Q1 25 | — | 6.8% | ||
| Q4 24 | — | 19.3% | ||
| Q3 24 | — | 27.3% | ||
| Q2 24 | — | 24.3% |
资本支出强度BRXRGEN
| Q1 26 | 3.4% | — | ||
| Q4 25 | — | 4.1% | ||
| Q3 25 | — | 2.5% | ||
| Q2 25 | — | 3.9% | ||
| Q1 25 | — | 2.1% | ||
| Q4 24 | — | 3.2% | ||
| Q3 24 | — | 4.5% | ||
| Q2 24 | — | 3.1% |
现金转化率BRXRGEN
| Q1 26 | — | — | ||
| Q4 25 | 4.75× | 1.93× | ||
| Q3 25 | 1.79× | 3.23× | ||
| Q2 25 | 2.13× | 1.92× | ||
| Q1 25 | 1.87× | 2.57× | ||
| Q4 24 | 7.49× | — | ||
| Q3 24 | 1.63× | — | ||
| Q2 24 | 2.62× | 12.70× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BRX
| Rental income | $354.3M | 100% |
| Other revenues | $482.0K | 0% |
RGEN
暂无分部数据
